Shaw Communications (USA) (SJR) Forms $21.05 Double Top; Investor Ab Trimmed Its Bristol Myers Squibb Co (BMY) Stake

May 19, 2017 - By Vivian Park

Investor Ab decreased Bristol Myers Squibb Co (BMY) stake by 82.72% reported in 2016Q4 SEC filing. Investor Ab sold 19,025 shares as Bristol Myers Squibb Co (BMY)’s stock 0.00%. The Investor Ab holds 3,975 shares with $232,000 value, down from 23,000 last quarter. Bristol Myers Squibb Co now has $88.03B valuation. The stock rose 0.52% or $0.28 reaching $54.06. About 1.42M shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Shaw Communications Inc (USA) (SJR) formed double top with $22.94 target or 9.00% above today’s $21.05 share price. Shaw Communications Inc (USA) (SJR) has $10.49B valuation. About 36,209 shares traded. Shaw Communications Inc (USA) (NYSE:SJR) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Among 17 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 7 Hold. Therefore 41% are positive. Bristol-Myers Squibb Company had 37 analyst reports since July 28, 2015 according to SRatingsIntel. Deutsche Bank maintained Bristol-Myers Squibb Co (NYSE:BMY) rating on Friday, October 28. Deutsche Bank has “Hold” rating and $52 target. The stock has “Hold” rating by Jefferies on Tuesday, March 15. The stock has “Hold” rating by Jefferies on Tuesday, June 14. The stock has “Hold” rating by Berenberg on Thursday, August 11. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Buy” rating by UBS on Friday, April 29. BMO Capital Markets downgraded the stock to “Market Perform” rating in Monday, January 25 report. The firm earned “Equal-Weight” rating on Friday, September 9 by Barclays Capital. The rating was maintained by Barclays Capital on Friday, April 29 with “Equal Weight”. Citigroup maintained it with “Buy” rating and $70 target in Tuesday, September 20 report. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Outperform” rating by Credit Suisse on Monday, May 9.

Investors sentiment decreased to 0.97 in 2016 Q4. Its down 0.16, from 1.13 in 2016Q3. It dropped, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Oppenheimer & Inc owns 351,691 shares or 0.6% of their US portfolio. Roffman Miller Pa reported 9,418 shares. Asset invested in 0.08% or 7,108 shares. Virginia Retirement Et Al invested 0.2% in Bristol-Myers Squibb Co (NYSE:BMY). Lba Wealth Management Limited Liability Corporation invested 0.07% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Creative Planning invested 0.12% in Bristol-Myers Squibb Co (NYSE:BMY). Chatham Cap Group Incorporated Incorporated owns 7,647 shares. Rockefeller, New York-based fund reported 25,024 shares. Obermeyer Wood Inv Counsel Lllp holds 0.09% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 15,645 shares. Nuveen Asset Management Lc stated it has 217,258 shares. Bb&T Corp stated it has 264,674 shares. Sumitomo Mitsui Trust Hldgs Inc reported 4.89M shares or 0.47% of all its holdings. Murphy Pohlad Asset Management Ltd Liability Corp reported 17,288 shares. Price T Rowe Associate Md holds 0.43% or 37.02M shares. Minnesota-based Meristem Ltd Liability Partnership has invested 0.42% in Bristol-Myers Squibb Co (NYSE:BMY).

Since February 27, 2017, it had 1 insider buy, and 6 insider sales for $9.91 million activity. ANDREOTTI LAMBERTO sold 34,000 shares worth $1.81M. 92,405 shares were sold by LEUNG SANDRA, worth $5.27M on Friday, March 3. Caldarella Joseph C also sold $463,779 worth of Bristol-Myers Squibb Co (NYSE:BMY) on Wednesday, March 15. On Friday, March 17 Schmukler Louis S sold $282,470 worth of Bristol-Myers Squibb Co (NYSE:BMY) or 5,000 shares. 12,000 shares were bought by Samuels Theodore R. II, worth $681,240 on Monday, February 27.

Analysts await Bristol-Myers Squibb Co (NYSE:BMY) to report earnings on July, 27. They expect $0.73 EPS, up 5.80% or $0.04 from last year’s $0.69 per share. BMY’s profit will be $1.19 billion for 18.52 P/E if the $0.73 EPS becomes a reality. After $0.84 actual EPS reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -13.10% negative EPS growth.

Among 4 analysts covering Shaw Comms (NYSE:SJR), 2 have Buy rating, 1 Sell and 1 Hold. Therefore 50% are positive. Shaw Comms had 7 analyst reports since October 20, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets with “Sector Perform” on Thursday, December 17. The firm earned “Sell” rating on Thursday, April 6 by Citigroup. Barclays Capital maintained Shaw Communications Inc (USA) (NYSE:SJR) rating on Friday, October 23. Barclays Capital has “Equal Weight” rating and $22 target. The rating was upgraded by Macquarie Research to “Outperform” on Tuesday, October 20. RBC Capital Markets maintained the shares of SJR in report on Friday, October 23 with “Sector Perform” rating. The company was upgraded on Monday, January 9 by RBC Capital Markets. The rating was initiated by Barclays Capital on Tuesday, April 5 with “Equal-Weight”.